Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
PlaqueTec Ltd. logo — Opening a new frontier in the fight against atherosclerosis

PlaqueTec Ltd.

Opening a new frontier in the fight against atherosclerosis

Founded 2008 United Kingdom Cambridge, United Kingdom 5 employees Venture round Total: $6.40M Health Care

General Information

Company Name PlaqueTec Ltd.
Founded Year 2008
Location United Kingdom Cambridge, United Kingdom
Employees 5
Industries Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with PlaqueTec Ltd.. To contact PlaqueTec Ltd., visit plaquetec.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PlaqueTec Ltd. compare?

A PDF of PlaqueTec Ltd. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PlaqueTec Ltd. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PlaqueTec Ltd.

PlaqueTec Ltd. is revolutionizing the fight against atherosclerosis with their novel approach to understanding coronary artery disease (CAD). Their slogan, "Opening a new frontier in the fight against atherosclerosis," encapsulates their mission. CAD, a leading global cause of death, has been limited by one-size-fits-all treatments. However, PlaqueTec aims to change this narrative with their proprietary technology and data analysis platform. Founded in 2008 and based in the United Kingdom, the company recently secured a significant £6.40M in a Venture Round investment on 30 April 2024. This investment was led by the Future Fund and Lord Moynihan. Their focus on developing precision medicine through a deeper understanding of patient endotypes holds the potential to revolutionize drug development and treatment efficacy. PlaqueTec's pursuit of uncovering potential biomarkers of coronary vascular function and plaque progression signifies a promising shift towards tailored treatments. This approach not only has the potential to reduce clinical trial sizes and costs but also increase success rates, ultimately improving patient outcomes. In the Health Care sector, PlaqueTec's innovative strides offer a glimpse into the future of personalized medicine and targeted interventions in the fight against CAD.

Business keywords: Precision Medicine, Atherosclerosis, Coronary Artery Disease, Biomarker, Drug Development, Biopharmaceutical, Cardiology, Therapeutic Agents, Endotype, Clinical Trials, Inflammatory Processes, Plaque Progression, Vascular Function, Diagnostic Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round £6.40M 2
Future Fund
Future Fund, Lord Moynihan
30 Apr 2024

PlaqueTec Ltd. Alternatives & Competitors

View All Alternatives
PlaqueTec Ltd. vs
Mercator MedSystems, Inc.
Mercator MedSystems, Inc.

Mercator MedSystems, Inc., is a medical technology company focused on the treatment of peripheral ar...

Series D
16 employees
Biotechnology, Health Care
PlaqueTec Ltd. vs
Reven Pharmaceuticals
Reven Pharmaceuticals United States

Diligently pursuing scientific innovation to exponentially improve health and well-being.

Series D
14 employees
Biotechnology, Health Care
PlaqueTec Ltd. vs
Kaminari Medical
Kaminari Medical The Netherlands

Combining ultrasound and optical imaging to revolutionize coronary revascularization

Seed
10 employees
Health Care, Medical Devices
View all alternatives

FAQ About PlaqueTec Ltd.

Opening a new frontier in the fight against atherosclerosis
PlaqueTec Ltd. was founded in 2008.
PlaqueTec Ltd. is headquartered in Cambridge, United Kingdom.
PlaqueTec Ltd. operates in Health Care. Its work centres on Precision Medicine, Atherosclerosis, Coronary Artery Disease and Biomarker.
PlaqueTec Ltd. has approximately 5 employees.
PlaqueTec Ltd. has completed 1 funding round, raising a total of $6.40M. The latest funding stage is Venture round.
Top alternatives and competitors to PlaqueTec Ltd. include Mercator MedSystems, Inc., Reven Pharmaceuticals, Kaminari Medical, Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), OncXerna Therapeutics . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PlaqueTec Ltd. and Mercator MedSystems, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PlaqueTec Ltd., https://bouncewatch.com/company/plaquetec-ltd, updated 21 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout